• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 REACT CATHETER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 REACT CATHETER; CATHETER, PERCUTANEOUS Back to Search Results
Model Number REACT-68
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 02/24/2024
Type of Reportable Event Serious Injury
Event or Problem Description
Medtronic received a report that the marker band on the react catheter fell off and remains in the patient.The patient was undergoing a posterior cerebral artery thrombectomy.The accessed vessel was the femoral artery with a diameter of 5 mm.It was noted the patient's vessel tortuosity was minimal.It was reported that during the thrombectomy operation, the surgeon used react 68 to perform the operation.During the operation, he found that the marker point at the tip of the catheter fell off.He tried many times to pass the stent through the marker, but failed to pull it out.In order to prevent the marker from moving, an ep stent was inserted and pressed it into the blood vessel where it fell.  it was reported the marker band dislodged/ was damaged.The catheter tip was shaped.The catheter tip was shaped as indicated in the ifu.The marker band remains in the patient in the posterior cerebral artery.The reported device and any accessory devices were prepared as indicated in the instructions for use (ifu).  the catheter was flushed as indicated in the ifu.No patient symptoms or further complications were reported as a result of this event.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported the patient's symptoms in presenting for stroke treatment were gradually worsening level of consciousness and coma, with no other obvious stroke symptoms.The index clot being treated was located in the basilar artery.The patient's pre-procedure nihss was 36 and tici was 1.Tici 3 was achieved in the procedure and the patient's post-procedure nihss was 28.The patient was recovering well.Dual antiplatelet therapy was administered to prevent thrombosis of the catheter marker.
 
Additional Manufacturer Narrative
B5.Updated with additional information received.Imf/annex f code updated based on available information.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REACT CATHETER
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18789082
Report Number2029214-2024-00344
Device Sequence Number15407338
Product Code DQY
UDI-Device Identifier00847536041967
UDI-Public00847536041967
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K180715
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/22/2025
Device Model NumberREACT-68
Device Catalogue NumberREACT-68
Device Lot NumberB525096
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/25/2024
Supplement Date Received by Manufacturer02/29/2024
05/20/2024
Initial Report FDA Received Date02/27/2024
Supplement Report FDA Received Date03/21/2024
05/20/2024
Date Device Manufactured02/28/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age66 YR
Patient SexFemale
Patient Weight56 KG
-
-